Remotiv® – Ze 117

Remotiv® – Ze 117

Remotiv® – Ze 117

Treatment of mild to moderate depressive episodes.

  • Non-inferiority to standard drugs
  • recommended “First-line” treatment
  • Low drug-drug interaction risk

This is an authorised medicinal product.

Max Zeller Söhne AG, 8590 Romanshorn

Product information

For the treatment of mild to moderate depressions (WHO ICD10 F32.0/F32.1)

Remotiv 250®: 250 mg of dry extract (Ze 117) from Hypericum perforatum L. herba

Remotiv 500®: 500 mg of dry extract (Ze 117) from Hypericum perforatum L. herba

Drug-extract ratio (DER): 4-7:1

Extraction solvent: 57.9% ethanol (V/V)

Remotiv 250®: 2 film-coated tablets per day.

Remotiv 500®: 1 film-coated tablet per day.

Recommended for minimum 6 weeks.

Clinical Evidence & Mode of action

The information contained in this section is intended for healthcare professionals only.

Please click the button below to confirm that you are a healthcare professional.


Get in Touch

Max Zeller Soehne AG Seeblickstr. 4 8590 Romanshorn Switzerland

P: +41 71 466 05 00

Ze 117 – The Difference

Effective natural mood enhancer – Comparable efficacy to SSRIs in mild/moderate depression and high responder rates, shown by clinical studies

Triple action – Inhibits presynaptic reuptake of dopamine, serotonin and noradrenaline

First-line therapy – Proposed by doctors in various guidelines as first-line treatment for mild to moderate depression

Excellent safety – Ze 117 is better tolerated than SSRIs and has very low potential for drug-drug interactions due to special extract containing low hyperforin levels (≤1%), suitable for long-term treatment

Moderne-Pflanzenheilkunde-Phytotherapie.jpg Moderne-Pflanzenheilkunde-Phytotherapie.jpg


Our phyto-pharmaceuticals have proven efficacy, tolerability and safety in numerous clinical trials performed by Zeller and published in peer-reviewed journals.


Further products